Immunosuppressive therapy of autoimmune hypoparathyroidism in a patient with activating autoantibodies against the calcium-sensing receptor

Article English OPEN
Chamberlin, M.; Kemp, E.H.; Weetman, A.P.; Khadka, B.; Brown, E.M.;
  • Publisher: Wiley

Context\ud Activating antibodies directed at the extracellular calcium‐sensing receptor (CaSR) have been described in autoimmune hypoparathyroidism in the setting of isolated hypoparathyroidism or autoimmune polyglandular syndrome type 1.\ud \ud Materials and methods\ud... View more
Share - Bookmark